Reboxetine (brand names: Edronax (AU, IE, IL, NZ, ZA, UK), Prolift (AR,† BR, CL, VE†)) is a drug of the norepinephrine reuptake inhibitor class, marketed as an antidepressant by Pfizer for use in the treatment of unipolar depression, although it has also been used off-label for panic disorder and ADHD. It is approved for use in many countries worldwide, but has not been approved for use in the United States. Although its efficacy as an antidepressant has been challenged in multiple published reports, its popularity has continued to increase.

CAS：98769-84-7
中文别名：瑞波西汀马来酸盐;2-[(2-乙氧基苯氧基)苯甲基]吗啉甲磺酸盐;甲磺酸瑞波西汀;
英文别名：EDRONAX;Reboxetine (mesylate);REBOXETIN MESYLATE;Reboxetinemesylate;REBOXETINE,MESYLATE;RAC-N-BENZYL-N-[2-HYDROXYL-2-(4-BENZYLOXY-3-FORMAMIDOPHENYL)-ETHYL]-3-(4-METHOXYPHENYL)-2-PROPYLAMINE-D6;REBOXETINE MESYLATE HYDRATE;REBOXETINE, MESYLATE;REBOXETINE MESILATE;(2R)-rel-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine;Reboxetine hydrate mesylate;VESTRA;2-[(2-Ethoxyphenoxy)phenylmethyl]morpholine mesylate;
分子式：C20H27NO6S
分子量：409.496
精确质量：409.156
Psa：102.47
Logp：4.1074

外观与性状：黄褐色或灰白色水晶般的固体
沸点：443.7ºC at 760 mmHg
熔点：170-171ºC
闪点：188.2ºC
储存条件：2-8ºC

安全说明：S22-S24/25